FDA approves first COVID-19 drug: the antiviral remdesivir

News

FILE – In this March 2020 photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)

(AP) – U.S. regulators have approved the first drug to treat COVID-19. Remdesivir is an antiviral medicine given through an IV for patients needing hospitalization.

Its maker, Gilead Sciences Inc., said Thursday that the drug is approved for people at least 12 years old who need hospitalization for their coronavirus infection.

The company is calling it Veklury.

A large U.S. study found it cut the time to recovery by five days — from 15 days to 10 on average.

It has been authorized for use on an emergency basis since spring. It works by inhibiting a substance the virus uses to make copies of itself.

(Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.)

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Mascot Challenge
High School RedZone
Star of the Week
Black and Blue Kickoff Live
Pro Football Challenge
Carolina Eats Contest
Find A Job
Color your Weather
wspa news app free for download choose your store below
download the wspa news app from the apple app store
download the wspa news app from the google play store

Trending Stories